A Seminar on the New Rapid Testing System for Identification of Bacteria (Tm Mapping Method) to be Offered at Singapore International Infectious Disease Conference



Mitsui Chemicals, Inc.

Mitsui Chemicals, Inc. (Location: Minato-ku, Tokyo; President & CEO: Tsutomu Tannowa) will offer a sponsored session on the rapid testing system for the identification of bacteria at the Singapore International Infectious Disease Conference (SIIDC) to be held in Singapore from August 24 to 26, 2017.

Working with the University of Toyama (Location: Toyama City, Toyama; President: Shunro Endo), Mitsui Chemicals, Inc. aims to commercialize the new testing system (Tm Mapping Method) to rapidly identify the causative bacteria of sepsis. The system is a molecular diagnostic testing system that identifies the pathogenic bacteria within about five hours after blood collection without requiring a blood culture, and expected to make it possible to choose the appropriate antibiotics based on the identified pathogen at the early stage of infection.
In this session, four medical doctors, including the inventor, Dr. Hideki Niimi from Toyama University Hospital, will talk about the current situation of rapid testing methods in Singapore and Japan, Tm Mapping Method, and its result of the clinical research. A summary of the session is as follows:

Summary of SIIDC Satellite Session

Topic New Rapid Identification System for Sepsis-Causing Bacteria without Blood Culture
- Development and Clinical Study -
Time & Date From 5:45 pm to 7:15 pm, August 25, 2017
Location Galleria, Level 3, Grand Copthorne Waterfront Hotel Singapore
Chair Dr. Tan Thean Yen
Senior Consultant & Head, Molecular Lab, Pathology, Singapore General hospital, Singapore
Speaker Dr. Lynette Oon
Senior Consultant & Head, Molecular Lab, Pathology, Singapore General hospital, Singapore
Professor Kastunori Yanagihara
Department of Laboratory Medicine, Nagasaki University Graduate School or Biomedical Sciences, Japan
Associate Professor Hideki Niimi
Clinical Laboratory and Molecular Pathology, University of Toyama, Japan
Dr. Yuji Uejima
Senior Consultant, Division of Infectious Diseases and Immunology, and Allergy,
Saitama Children’s Medical Center, Japan

SIIDC official website: http://www.siidc.com.sg/

This research is supported by Japan Agency for Medical Research and Development (AMED) in the Innovation Set-up Scheme, Acceleration Transformative Research for Medical Innovation (ACT-M). In this scheme, the University of Toyama is the representative research institute, and Mitsui Chemicals, Inc. is the set-up company.

AMED website: http://www.amed.go.jp/en/